CRL
Charles River Laboratories Inte · Healthcare · Diagnostics & Research
TECHStrong BuyZACKSBuy
R500#125 today
$290.19
+1.17% today · -0.90% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- CRL +1.17% on the last session vs SPY +0.74%: +0.4 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 58 big drops in the past 5 years, CRL typically gained 0.4% over the next day (median) and was higher 60% of the time; half the outcomes fell between -0.7% and +1.5%. An ordinary day: -0.0%. Among S&P 500 stocks after big drops, that ranks #139 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
CRL against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #125 | +1.17% | +0.74% | |
| 1 week | #242 | -0.90% | -0.22% | |
| 1 month | #133 | -0.54% | +0.84% | |
| 3 months | #29 | +25.79% | +3.59% | |
| 6 months | #27 | +66.88% | +17.95% | |
| 1 year | #46 | +65.48% | +16.25% | |
| Overall | #43 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Diagnostics & Research
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.11 | #390 | #3 |
| fPE/tPE | #1 | #1 | |
| PE/G | 0.12 | #2 | #1 |
| EV/Revenue | 4.19 | #224 | #9 |
| Gross Margin | 0.35 | #346 | #9 |
| Profit Margin | -0.06 | #476 | #12 |
| Revenue Growth | -0.03 | #447 | #12 |